<DOC>
	<DOCNO>NCT00575601</DOCNO>
	<brief_summary>The purpose study determine whether simvastatin effective improvement IVF-ICSI outcome Pcos patient .</brief_summary>
	<brief_title>Effects Simvastatin Biochemical Parameters Outcome IVF-ICSI Pcos Patients</brief_title>
	<detailed_description>simvastatin reduces cardiovascular risk improve hypercholesterolemia , reduce vascular smooth muscle proliferation , ameliorate inflammation , limit theca-interstitial proliferation &amp; decrease steroidogenesis ( production progesterone &amp; testosterone ) .Polycystic ovary syndrome ( pcos ) associate increased cardiovascular risk characterize ovarian theca-interstitial hyperplasia &amp; hyperandrogenism .This study test hypothesis simvastatin improve biochemical parameter &amp; IVF-ICSI outcome Pcos patient .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Pcos patient Age &lt; 40 year FSH &lt; 10 IU/L Endometriosis grade 3 &amp; 4 History tubal surgery Hydrosalpinx History mellitis diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>pco</keyword>
	<keyword>simvastatin</keyword>
	<keyword>ivf</keyword>
	<keyword>embryo transfer</keyword>
</DOC>